|
Oct 4
|
Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings
|
|
Aug 1
|
NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health Month
|
|
Jul 31
|
Neuronetics to Present at the Canaccord Genuity 44th Annual Growth Conference
|
|
Jul 30
|
Neuronetics Announces the Closing of up to $90 Million Senior Secured Credit Facility with Perceptive Advisors
|
|
Jul 29
|
Neuronetics (NASDAQ:STIM) shareholders have endured a 85% loss from investing in the stock three years ago
|
|
Jul 29
|
Neuronetics to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call
|
|
Jul 22
|
Aetna Policy Update Expands TMS Availability for Adolescents With Depression
|
|
May 15
|
Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
|
|
May 9
|
Neuronetics, Inc. (NASDAQ:STIM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
|
|
May 8
|
Neuronetics, Inc. (NASDAQ:STIM) Q1 2024 Earnings Call Transcript
|
|
May 8
|
Neuronetics Inc (STIM) (Q1 2024) Earnings Call Transcript Highlights: Strategic Growth Amidst ...
|
|
May 8
|
Q1 2024 Neuronetics Inc Earnings Call
|
|
May 7
|
Neuronetics Inc (STIM) Reports Q1 2024 Earnings: Revenue Surpasses Estimates, Narrowing Losses
|
|
May 7
|
Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 7
|
Neuronetics Reports Record First Quarter 2024 Financial and Operating Results
|
|
May 1
|
NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month
|
|
Apr 23
|
Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call
|
|
Apr 10
|
New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
|
|
Apr 1
|
Neuronetics' (STIM) FDA-Cleared NeuroStar to Aid in Depression
|
|
Mar 27
|
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
|